<DOC>
	<DOCNO>NCT01458964</DOCNO>
	<brief_summary>Is quetiapine effective medication treatment fibromyalgia .</brief_summary>
	<brief_title>Quetiapine Compared With Placebo Management Fibromyalgia</brief_title>
	<detailed_description>This study double blind , placebo control , 24-week crossover design . For 12 week subject receive either study medication ( 200mg Quetiapine ) placebo , switch treatment additional 12 week . Between treatment , subject require undergo 1-week washout drug give order clear effect first treatment . At visit subject complete follow assessment : Fibromyalgia Impact Questionnaire , Pittsburgh Sleep Quality Index , Beck Depression Inventory , State-Trait Anxiety Inventory , Short Form Health Survey . Temperature , blood pressure , pulse rate , weight waist circumference also record . Physical exams blood test perform 1 , 12 , 25 week</detailed_description>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Age 18 60 , inclusive Females childbearing potential use reliable method contraception AND negative urine pregnancy test . Widespread pain present least 3 month Widespread encompass side body , well waist Pain least 11 18 tender point determine physician Exclusion Criteria : Pregnant breastfeeding Use follow 14 day prior enrollment : ketoconazole , itraconazole , fluconazole , erythromycin , clarithromycin , troleandomycin , indinavir , nelfinavir , ritonavir , fluvoxamine , saquinavir phenytoin , carbamazepine , barbiturate , rifampin , St. John 's Wort , glucocorticoid . Administration depot antipsychotic injection within one dose interval ( depot ) enrollment Substance alcohol dependence enrollment ( except full recovery , except nicotine caffeine dependence ) Abuse follow within 4 week enrollment : opiate , amphetamine , barbiturate , cocaine , cannabis , hallucinogen Medical condition would affect study treatment Unstable inadequately treat medical illness ( e.g . diabetes , angina pectoris , hypertension ) judge investigator Involvement planning conduct study Previous enrollment randomization treatment present study Participation another drug trial within 4 week prior enrollment study longer Admitted hospital Diabetes Mellitus ( DM ) relate illness past 12 week Not physician 's care DM Physician responsible DM care indicate DM uncontrolled Physician responsible DM care approve participation study Have dose DM medicine and/or diet 4 week prior start study For thiazolidinediones ( glitazones ) period le 8 week Taking insulin whose daily one occasion past 4 week 10 % mean dose precede 4 week A low white blood cell count</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Fibromyalgia</keyword>
</DOC>